NO20060977L - Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter - Google Patents

Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter

Info

Publication number
NO20060977L
NO20060977L NO20060977A NO20060977A NO20060977L NO 20060977 L NO20060977 L NO 20060977L NO 20060977 A NO20060977 A NO 20060977A NO 20060977 A NO20060977 A NO 20060977A NO 20060977 L NO20060977 L NO 20060977L
Authority
NO
Norway
Prior art keywords
compounds
mitokinone
mitochondrial
seeking
antioxidants
Prior art date
Application number
NO20060977A
Other languages
English (en)
Other versions
NO337925B1 (no
Inventor
Kenneth Taylor
Robin Smith
Original Assignee
Antipodean Parmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antipodean Parmaceuticals Inc filed Critical Antipodean Parmaceuticals Inc
Publication of NO20060977L publication Critical patent/NO20060977L/no
Publication of NO337925B1 publication Critical patent/NO337925B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår farmasøytisk akseptable amfifile antioksidantforbindelser, sammensetninger og doseringsformer omfattende nevnte forbindelser, og fremgangsmåter og anvendelser basert på nevnte forbindelser. De eksemplifiserte forbindelsene er alle mitokinon-derivater, og er metoksyfenylalkyltrifenylfosfonium- eller metoksydioksocykloheksadienalkyltrifenylfosfonium-derivater. Forbindelsene, sammensetningene, doseringsformene, anvendelsene og fremgangsmåtene er for eksempel anvendelige i behandling av sykdommer eller tilstander assosiert med oksidativt stress.
NO20060977A 2003-08-22 2006-02-28 Antioksidantforbindelse samt anvendelse og fremstilling derav, farmasøytisk sammensetning, og fremgangsmåte for redusering av oksidativt stress i en celle in vitro NO337925B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ52780003 2003-08-22
NZ52915303 2003-10-23
NZ53355604 2004-06-14
PCT/NZ2004/000196 WO2005019232A1 (en) 2003-08-22 2004-08-23 Mitoquinone derivatives used as mitochondrially targeted antioxidants

Publications (2)

Publication Number Publication Date
NO20060977L true NO20060977L (no) 2006-05-19
NO337925B1 NO337925B1 (no) 2016-07-11

Family

ID=34222195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060977A NO337925B1 (no) 2003-08-22 2006-02-28 Antioksidantforbindelse samt anvendelse og fremstilling derav, farmasøytisk sammensetning, og fremgangsmåte for redusering av oksidativt stress i en celle in vitro

Country Status (8)

Country Link
EP (1) EP1664069B8 (no)
KR (1) KR100974202B1 (no)
AU (1) AU2004266988B2 (no)
BR (1) BRPI0413742B8 (no)
CA (1) CA2536546C (no)
NO (1) NO337925B1 (no)
RU (1) RU2487880C2 (no)
WO (2) WO2005019233A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
SG145715A1 (en) 2003-08-22 2008-09-29 Antipodean Pharmaceuticals Inc Mitoquinone derivatives used as mitochondrially targeted antioxidants
US20070225255A1 (en) * 2004-07-13 2007-09-27 Eleonore Frohlich Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers
ES2714900T3 (es) 2005-06-01 2019-05-30 Bioelectron Tech Corp Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
RU2318500C2 (ru) * 2005-10-18 2008-03-10 Общество С Ограниченной Ответственностью "Митотехнология" Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
JP5616798B2 (ja) * 2008-03-14 2014-10-29 スティーブン・ジョン・ラルフＳｔｅｐｈｅｎ Ｊｏｈｎ ＲＡＬＰＨ ミトコンドリア由来の抗ガン化合物
CN102046178B (zh) * 2008-04-01 2013-05-08 安蒂博汀医药公司 用于皮肤护理的组合物和方法
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
ES2634423T3 (es) * 2008-10-06 2017-09-27 Elizabeth Arden International, Sarl Tratamientos para la piel que contienen derivados de idebenona sustituidos con ácido carboxílico y métodos de preparación y utilización de los mismos
WO2011108946A1 (en) * 2010-03-04 2011-09-09 Androgenix Ltd Methods for improving sperm functionality
RU2527519C2 (ru) * 2010-06-24 2014-09-10 Общество С Ограниченной Ответственностью "Митотех" Мягкие катионные митохондриальные разобщители
EP2750662A4 (en) 2011-08-31 2015-06-24 Univ Georgia NANOPARTICLES TARGETING APOPTOSIS
US9434753B2 (en) 2011-09-19 2016-09-06 Gencia Corporation Modified creatine compounds
US10806703B2 (en) 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
ES2669561T3 (es) 2012-02-17 2018-05-28 University Of Georgia Research Foundation, Inc. Nanopartículas para el transporte mitocondrial de agentes
WO2015138992A1 (en) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate
US9314457B2 (en) 2014-06-19 2016-04-19 The University Of Utah Research Foundation Methods of treating and preventing vascular instability diseases
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
RU2020120686A (ru) 2017-11-24 2021-12-24 Лунелла Байотек, Инк. Соединения производных трифенилфосфония для эрадикации раковых стволовых клеток
WO2020154724A1 (en) * 2019-01-25 2020-07-30 Vanderbilt University Mitochondria-targeted isoketal/isolevuglandin scavengers
DE102019218241A1 (de) * 2019-11-26 2021-05-27 Beiersdorf Ag Wirkstoffkombinationen aus Ubichinol und Carrageenan und kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
GB2610815A (en) * 2021-09-14 2023-03-22 Mitorx Therapeutics Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331532B1 (en) * 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants
JP4590523B2 (ja) * 1997-11-25 2010-12-01 アンティポディーン ファーマシューティカルズ インコーポレイテッド ミトコンドリアを標的とする抗酸化剤
NZ513547A (en) * 2001-08-13 2002-09-27 Antipodean Biotechnology Ltd Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)

Also Published As

Publication number Publication date
EP1664069B8 (en) 2015-07-01
WO2005019232A1 (en) 2005-03-03
KR20070018766A (ko) 2007-02-14
EP1664069A4 (en) 2009-09-30
WO2005019233A1 (en) 2005-03-03
EP1664069A1 (en) 2006-06-07
BRPI0413742B8 (pt) 2021-05-25
BRPI0413742A (pt) 2006-10-24
AU2004266988B2 (en) 2011-05-26
EP1664069B1 (en) 2015-04-08
RU2006109020A (ru) 2007-09-27
KR100974202B1 (ko) 2010-08-06
NO337925B1 (no) 2016-07-11
CA2536546C (en) 2012-10-02
RU2487880C2 (ru) 2013-07-20
AU2004266988A1 (en) 2005-03-03
CA2536546A1 (en) 2005-03-03
BRPI0413742B1 (pt) 2019-05-21

Similar Documents

Publication Publication Date Title
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
SG145715A1 (en) Mitoquinone derivatives used as mitochondrially targeted antioxidants
ECSP055780A (es) Derivados de indol utiles para el tratamiento de enfermedades
CL2004000849A1 (es) Compuestos derivados de benzamidas-2-hidroxi-3-diaminoalcanos, utiles para el tratamiento o la prevencion de alzheimer, sindrome de down, hemorragia cerebral hereditaria, demencias degenerativas y otras.
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
ECSP066972A (es) Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
SV2004001691A (es) Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen compuestos y sus usos
UY28339A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
IS8175A (is) Píperasín afleiður og aðferðir við notkun þeirra
NO20064584L (no) Tetrahydropyridoindolderivater
CL2004000848A1 (es) Compuestos derivados de fenacil-2-hidroxi-3-diaminoalcanos, inhibidores de la enzima betasecretasa, utiles para preparar un medicamento para tratar alzheimer, sindrome de down, hemorragia cerebral hereditaria con amiloidosis de tipo holandes, y otras
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
TW200507830A (en) Bronchodilating β -agonist compositions and methods
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
WO2005112915A3 (en) Decrease in oxidative stress status through the administration of natural products and pharmaceutical drugs
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
CL2003002769A1 (es) Compuestos derivados de carboxamida de tiazolilpirrol; procedimiento para su preparacion; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento y/o profilaxis de enfermedades asociadas con la modulacion de receptores canabinoid
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
NO20062878L (no) Isoflavonoidpromedikamenter, terapeutiske sammensetninger derav og terapeutiske fremgangsmater som innbefatter de samme
UY27969A1 (es) Formulaciones que comprenden un compuesto de indolinona
UY28317A1 (es) Compuestos útiles para el tratamiento de enfermedades
NO20070502L (no) Azaindoler nyttige som inhibitorer av proteinkinaser